Drugs / autologous peripheral mononuclear cells with CD34+ stem cells
autologous peripheral mononuclear cells with CD34+ stem cells
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01615250 Comparator | Jan 2012 → Jan 2015 | heart failure | Odessa National Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous peripheral mononuclear cells with CD34+ stem cells | “Intramyocardial implantation of autologous peripheral mononuclear cells with CD34+ stem cells by NOGA.XP navigation system.” NCT01615250 ↗ |
| Modality | Cell therapy | “peripheral mononuclear cells with CD34+ stem cells” NCT01615250 ↗ |
| Route | Other | “Intramyocardial implantation of autologous peripheral mononuclear cells with CD34+ stem cells” NCT01615250 ↗ |